Reports for PRO DOC LIMITEE
Company Name
PRO DOC LIMITEE
Totals |
||
Shortage reports |
346 |
|
Actual shortage: | 10 (3%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 7 (2%) | |
Resolved: | 329 (95%) | |
Discontinuation Reports |
149 |
|
To be discontinued: | 1 (1%) | |
Discontinued: | 144 (97%) | |
Reversed: | 4 (3%) | |
Late reports |
16 (3%) |
|
Overdue reports |
6 (55%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MOXIFLOXACIN | 400MG | TABLET | Resolved | 2024-11-04 | 2025-03-10 | 241981 |
MOXIFLOXACIN | 400MG | TABLET | Resolved | 2023-02-03 | 2023-05-18 | 183506 |
MOXIFLOXACIN | 400MG | TABLET | Resolved | 2019-01-24 | 2019-07-31 | 73443 |
NAPROXEN-NA | 275MG | TABLET | Resolved | 2017-11-06 | 2018-07-27 | 28244 |
NAPROXEN-NA DF | 550MG | TABLET | Resolved | 2017-04-07 | 2017-12-13 | 6195 |
NIFEDIPINE ER | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-06-08 | 2020-11-25 | 116853 |
NIFEDIPINE ER | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-04-26 | 2019-06-06 | 82477 |
NIFEDIPINE ER | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-07-21 | 2018-10-05 | 16633 |
NIFEDIPINE ER | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-01-03 | 2020-10-24 | 102154 |
NIFEDIPINE ER | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-09-07 | 2018-10-06 | 21244 |
NIFEDIPINE ER | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-03-03 | 2020-04-24 | 107625 |
NIFEDIPINE ER | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-05-16 | 2019-08-09 | 84244 |
NIFEDIPINE ER | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-01-03 | 2020-02-07 | 102157 |
OLANZAPINE | 10MG | TABLET | Resolved | 2024-02-02 | 2024-02-26 | 218231 |
OLANZAPINE | 2.5MG | TABLET | Resolved | 2018-03-06 | 2018-04-18 | 41935 |
OLANZAPINE | 5MG | TABLET | Resolved | 2018-04-17 | 2018-04-21 | 46186 |
OLANZAPINE | 10MG | TABLET | Resolved | 2018-05-10 | 2018-06-12 | 49030 |
OLANZAPINE | 20MG | TABLET | Resolved | 2018-08-29 | 2019-07-04 | 59473 |
OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-14 | 2018-11-03 | 2320 |
OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-12-02 | 2021-01-09 | 129280 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2025-04-04 | 2025-04-05 | 254240 |
RIVASTIGMINE | 6MG | CAPSULE | To be discontinued | 2025-04-04 | 2025-04-04 | 254243 |
TEMAZEPAM-15 | 15MG | CAPSULE | Discontinued | 2017-05-08 | 2017-05-08 | 9551 |
TEMAZEPAM-30 | 30MG | CAPSULE | Discontinued | 2017-05-08 | 2017-05-08 | 9554 |
TERAZOSIN-2 | 2MG | TABLET | Discontinued | 2021-06-25 | 2021-08-12 | 141500 |
TERAZOSIN-5 | 5MG | TABLET | Discontinued | 2021-06-25 | 2021-07-28 | 141503 |
TRAMADOL-ACET | 37.5MG 325MG | TABLET | Discontinued | 2019-07-24 | 2019-09-12 | 89923 |
ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2021-04-07 | 2021-04-08 | 137050 |
ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-04-02 | 2021-04-03 | 136790 |